BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin X, Xu F, Zhang K, Qiu W, Zhang H, Hao Q, Li M, Deng X, Tian Y, Chen Z, Qian A. Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis. Front Cell Dev Biol 2022;10:796227. [DOI: 10.3389/fcell.2022.796227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Luo Y, Xu J, Guo C, Shi J, Li L, Sun X, Kong Q. The Possible Role of Electrical Stimulation in Osteoporosis: A Narrative Review. Medicina (Kaunas) 2023;59. [PMID: 36676745 DOI: 10.3390/medicina59010121] [Reference Citation Analysis]
2 Qin Y, Chen ZH, Wu JJ, Zhang ZY, Yuan ZD, Guo DY, Chen MN, Li X, Yuan FL. Circadian clock genes as promising therapeutic targets for bone loss. Biomed Pharmacother 2023;157:114019. [PMID: 36423544 DOI: 10.1016/j.biopha.2022.114019] [Reference Citation Analysis]
3 Sun X, Song C, Zhang C, Xing C, Lv J, Bian H, Lv N, Chen D, Dong X, Liu M, Su L. An Acid-Sensitive Bone Targeting Delivery System Carrying Acacetin Prevents Osteoporosis in Ovariectomized Mice. Pharmaceuticals (Basel) 2022;16. [PMID: 36678499 DOI: 10.3390/ph16010002] [Reference Citation Analysis]
4 Qu Z, Zhang B, Kong L, Gong Y, Feng M, Gao X, Wang D, Yan L. Receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1043975] [Reference Citation Analysis]
5 Kang L, Zhang H, Jia C, Zhang R, Shen C. Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals. Front Pharmacol 2022;13:956355. [DOI: 10.3389/fphar.2022.956355] [Reference Citation Analysis]